Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News EyePoint Pharmaceuticals Inc EYPT

Healthcare
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the business of developing and commercializing ophthalmic products for the treatment of eye diseases. The Company's pipeline leverages its Durasert technology (Durasert) for sustained intraocular drug delivery, including delivery of EYP-1901, is an investigational sustained delivery treatment... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EYPT)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire 2 days ago

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

GlobeNewswire April 2, 2024

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire March 18, 2024

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire March 7, 2024

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

GlobeNewswire March 4, 2024

EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024

GlobeNewswire February 29, 2024

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

GlobeNewswire February 27, 2024

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire February 16, 2024

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

GlobeNewswire February 3, 2024
View More News ››

Opinion & Analysis (NDAQ:EYPT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EYPT)

EyePoint Pharmaceuticals to Present at the Guggenheim Health

Breaking News: $EYPT EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceWATERTOWN...
whytestocks - January 31, 2024

I "SEE" nothing but $$$$$$$ Coming our way!

Here's to LOOKING up!!
PumperGuy - January 22, 2024

EYEPOINT PHARMACEUTICALS: A BOON FOR EYE DISEASE PATIENTS

$EYPT Excited to share an article about EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) - the Company develops and commercializes...
AviseAnalytics - January 5, 2024
View more Bullboard ››

Multi-Metal Development Ltd

Multi-Metal Development Ltd

Multi-Metal Development Ltd is a Canada-based mining company. The Company's projects consist of CuMo Project in Idaho and ...
View More »